Hospital Boards Get a Dashboard Aimed at Unwarranted Variation
Hospitals have spent years trying to measure and reduce unwarranted variation in care, yet many of those efforts have failed to move far beyond aspiration. This BMJ leader describes a different approach: a clinical dashboard built from data already reported to executive boards and top-level leaders in Norwegian specialist healthcare. The goal is not more information for its own sake. The goal is a compact view of safety, quality, and use of services that leaders can actually act on.
The proposal is built around a simple but stubborn problem. Variation in clinical practice can reflect real patient need, but it can also reflect inconsistent care, uneven access, or local habits that have no clinical justification. When that happens, the consequences reach beyond spreadsheets. Patients may receive different care for the same condition depending on where they enter the system, and leaders may never see the pattern clearly enough to correct it.
The article frames the dashboard as an early development process rather than a finished solution. It draws on routinely reported measures already circulating at the executive level, which matters because hospital leaders are far more likely to use metrics that fit existing reporting structures than entirely new data streams. In practice, this means the dashboard is designed to sit where governance decisions already happen, not in a separate analytic silo that rarely influences boardroom priorities.
Why the Dashboard Is Organized Around Wennberg Categories
The framework used here is a modified version of Wennberg’s categorization of healthcare delivery. That structure divides variation into two broad domains: effective care and patient safety, and preference-sensitive and supply-sensitive care. The first group is where hospitals should expect strong adherence to evidence-based practice, because the clinical benefit is clear and variation is harder to justify. The second group captures decisions where care may legitimately differ according to patient values or available capacity, but where excessive divergence can still signal inefficiency or unequal practice.
This is a useful organizing principle because it forces leaders to ask different questions of different measures. A mortality signal after hospital admission is not interpreted the same way as variation in procedure volume. A survival measure invites scrutiny of outcomes and system performance; a utilization rate invites scrutiny of whether resource use matches need, preference, and evidence. Grouping these indicators together inside one dashboard keeps the focus on whether variation is clinically defensible rather than simply numerically interesting.
Outcome Measures and Utilization Rates Tell Different Stories
Effective care and patient safety are monitored here with outcome measures such as 30-day mortality after hospital admission and 5-year cancer survival. Those indicators are blunt in the best sense: they are meant to reveal whether the system is delivering what it should. If mortality or long-term survival diverges across hospitals or regions, the signal may point to differences in timeliness, treatment quality, follow-up, or broader system performance. These are not metrics that should be left to occasional review when a problem becomes obvious.
A separate part of the dashboard tracks utilisation rates for procedures selected on cost and volume to follow variation in preference-sensitive and supply-sensitive care. In that setting, the clinical question is not simply whether a procedure is being done, but whether it is being done more or less often than comparable services without a clearly justified reason. High or low use may reflect local practice culture, availability of staff or equipment, referral patterns, or different thresholds for intervention. When leaders see those patterns together, they can begin to separate acceptable clinical diversity from unwarranted drift.
Variation can hide in plain sight.
What Executive Leaders Can Actually Use
The central argument is straightforward: presenting quality indicators of patient safety, quality, and utilisation rates in a dashboard may help executive hospital boards and top-level leaders focus on unwarranted variation. In governance terms, that is a meaningful claim. Senior leaders do not need a vast menu of disconnected measures. They need a limited set of signals that show where care is stable, where it is inconsistent, and where the hospital may be drifting away from expected standards.
The appeal of a dashboard lies in compression. A board cannot realistically audit every clinical pathway in detail, but it can review a concise display that brings mortality, survival, and procedure use into the same line of sight. That design can make variation visible in a way that traditional annual reports often do not. It also creates a common language for clinicians and executives, which is important when the conversation turns from abstract quality goals to specific service lines, patient groups, or procedures.
There is also a practical behavioral element. Leaders are more likely to notice and repeatedly review measures that are simple, routine, and tied to system-level accountability. A dashboard can turn isolated figures into a recurring management tool. Once patterns are visible over time, the board can ask harder questions: Is the variation justified? Is it consistent with evidence? Does it reflect patient preference or structural imbalance? Are certain units repeatedly outside the expected range?
A Governance Tool, Not a Finished Quality Solution
The article does not claim that dashboards alone solve unwarranted variation. It presents the initial process of development, which is a narrower and more defensible claim. A dashboard can point decision-makers toward potential problems, but it cannot on its own explain why the problem exists or how to fix it. Some signals will require clinical review, local context, and careful interpretation before any action is taken.
Still, the logic is strong. If hospitals want leaders to focus on safety, quality, and variation in use, the information has to be organized in a way that aligns with leadership responsibilities. The combination of outcome measures and utilization rates does exactly that. It connects bedside care to board-level oversight without pretending those two levels of the system operate in the same way.
A dashboard will not replace clinical judgment.
What it can do is make unwarranted variation harder to ignore. In a health system where the same data are often reported without changing practice, the value of this approach lies in its discipline: a limited, structured view of the metrics most likely to matter to executives, and most likely to reveal where care is drifting away from what patients should expect.